Table of Contents 1 Study Coverage 1.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Product 1.2 Market Segments 1.3 Key Manufacturers Covered 1.4 Market by Type 1.4.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth Rate by Product 1.4.2 primarily split into 1.4.3 Stent 1.4.4 PTA Balloon 1.5 Market by End User 1.5.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth Rate by End User 1.5.2 Hospital 1.5.3 Clinic 1.5.4 Other 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size 2.1.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue 2014-2025 2.1.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales 2014-2025 2.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Growth Rate by Regions 2.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Regions 2.2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Regions 3 Breakdown Data by Manufacturers 3.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Manufacturers 3.1.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Manufacturers 3.1.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Manufacturers 3.1.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Concentration Ratio (CR5 and HHI) 3.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Manufacturers 3.2.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Manufacturers (2014-2019) 3.2.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Manufacturers (2014-2019) 3.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Manufacturers 3.4 ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturing Base Distribution, Product Types 3.4.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers ICAD (Intracranial Atherosclerotic Disease) Pathology Product Type 3.4.3 Date of International Manufacturers Enter into ICAD (Intracranial Atherosclerotic Disease) Pathology Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Product 4.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Product 4.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Product 4.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Product 5 Breakdown Data by End User 5.1 Overview 5.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Breakdown Data by End User 6 North America 6.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology by Countries 6.1.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Countries 6.1.2 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Countries 6.1.3 United States 6.1.4 Canada 6.1.5 Mexico 6.2 North America ICAD (Intracranial Atherosclerotic Disease) Pathology by Product 6.3 North America ICAD (Intracranial Atherosclerotic Disease) Pathology by End User 7 Europe 7.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology by Countries 7.1.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Countries 7.1.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Countries 7.1.3 Germany 7.1.4 France 7.1.5 UK 7.1.6 Italy 7.1.7 Russia 7.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology by Product 7.3 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology by End User 8 Asia Pacific 8.1 Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology by Countries 8.1.1 Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Countries 8.1.2 Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Countries 8.1.3 China 8.1.4 Japan 8.1.5 Korea 8.1.6 India 8.1.7 Australia 8.1.8 Indonesia 8.1.9 Malaysia 8.1.10 Philippines 8.1.11 Thailand 8.1.12 Vietnam 8.1.13 Singapore 8.2 Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology by Product 8.3 Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology by End User 9 Central & South America 9.1 Central & South America ICAD (Intracranial Atherosclerotic Disease) Pathology by Countries 9.1.1 Central & South America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Countries 9.1.2 Central & South America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Countries 9.1.3 Brazil 9.2 Central & South America ICAD (Intracranial Atherosclerotic Disease) Pathology by Product 9.3 Central & South America ICAD (Intracranial Atherosclerotic Disease) Pathology by End User 10 Middle East and Africa 10.1 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology by Countries 10.1.1 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Countries 10.1.2 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Countries 10.1.3 GCC Countries 10.1.4 Turkey 10.1.5 Egypt 10.1.6 South Africa 10.2 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology by Product 10.3 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology by End User 11 Company Profiles 11.1 Stryker 11.1.1 Stryker Company Details 11.1.2 Company Business Overview 11.1.3 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Gross Margin (2014-2019) 11.1.4 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Products Offered 11.1.5 Stryker Recent Development 11.2 Balt 11.2.1 Balt Company Details 11.2.2 Company Business Overview 11.2.3 Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Gross Margin (2014-2019) 11.2.4 Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Products Offered 11.2.5 Balt Recent Development 11.3 TERUMO 11.3.1 TERUMO Company Details 11.3.2 Company Business Overview 11.3.3 TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Gross Margin (2014-2019) 11.3.4 TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Products Offered 11.3.5 TERUMO Recent Development 11.4 MicroPort 11.4.1 MicroPort Company Details 11.4.2 Company Business Overview 11.4.3 MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Gross Margin (2014-2019) 11.4.4 MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Products Offered 11.4.5 MicroPort Recent Development 11.5 Acandis 11.5.1 Acandis Company Details 11.5.2 Company Business Overview 11.5.3 Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Gross Margin (2014-2019) 11.5.4 Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Products Offered 11.5.5 Acandis Recent Development 12 Future Forecast 12.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Forecast by Regions 12.1.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Forecast by Regions 2019-2025 12.1.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Forecast by Regions 2019-2025 12.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Forecast by Product 12.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Forecast by Product 2019-2025 12.2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Forecast by Product 2019-2025 12.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Forecast by End User 12.4 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Forecast 12.5 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Forecast 12.6 Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Forecast 12.7 Central & South America ICAD (Intracranial Atherosclerotic Disease) Pathology Forecast 12.8 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Forecast 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Macroscopic Indicators 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables and Figures Figure ICAD (Intracranial Atherosclerotic Disease) Pathology Product Picture Table ICAD (Intracranial Atherosclerotic Disease) Pathology Market Segments Table Key Manufacturers ICAD (Intracranial Atherosclerotic Disease) Pathology Covered Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$) Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Product 2014-2025 Figure primarily split into Product Picture Table Major Manufacturers of primarily split into Figure Stent Product Picture Table Major Manufacturers of Stent Figure PTA Balloon Product Picture Table Major Manufacturers of PTA Balloon Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth Rate by End User 2019-2025 (K Units) Figure Hospital Figure Clinic Figure Other Figure ICAD (Intracranial Atherosclerotic Disease) Pathology Report Years Considered Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size 2014-2025 (Million US$) Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales 2014-2025 (K Units) Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Regions 2014-2019 (K Units) & (Million US$) Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Regions 2014-2019 (K Units) Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Regions 2014-2019 Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Regions 2014-2019 Figure 2018 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Regions Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Regions 2014-2019 (Million US$) Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Regions 2014-2019 Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Regions 2014-2019 Figure 2018 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Regions Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Manufacturers (2014-2019) (K Units) Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Share by Manufacturers (2014-2019) Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Share by Manufacturers in 2018 Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Manufacturers (2014-2019) (Million USD) Table ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Manufacturers (2014-2019) Figure ICAD (Intracranial Atherosclerotic Disease) Pathology Value Share by Manufacturers in 2018 Table Key Manufacturers ICAD (Intracranial Atherosclerotic Disease) Pathology Price (2014-2019) (USD/Unit) Table ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturers Manufacturing Base Distribution and Headquarters Table Manufacturers ICAD (Intracranial Atherosclerotic Disease) Pathology Product Type Table Date of International Manufacturers Enter into ICAD (Intracranial Atherosclerotic Disease) Pathology Market Table Manufacturers Mergers & Acquisitions, Expansion Plans Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Product (2014-2019) (K Units) Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Share by Product (2014-2019) Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Product (2014-2019) Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Product in 2018 Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Product (2014-2019) (Million US$) Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Product (2014-2019) Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Product (2014-2019) Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Product in 2018 Table ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Product 2014-2019 (USD/Unit) Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by End User (2014-2019) (K Units) Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Share by End User (2014-2019) Figure Global Sales ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by End User (2014-2019) Figure Global Sales ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by End User in 2018 Figure North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate 2014-2019 (K Units) Figure North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate 2014-2019 (Million US$) Table North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Countries (2014-2019) (K Units) Table North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Countries (2014-2019) Figure 2018 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Countries Table North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Countries (2014-2019) (Million US$) Table North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Countries (2014-2019) Figure 2018 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Countries Figure United States ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate (2014-2019) (K Units) Figure United States ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2014-2019) (K Units) Figure Canada ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate (2014-2019) (K Units) Figure Canada ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2014-2019) (Million US$) Figure Mexico ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate (2014-2019) (K Units) Figure Mexico ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2014-2019) (Million US$) Table North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Product (2014-2019) (K Units) Table North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Product (2014-2019) Figure 2018 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Product Table North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by End User (2014-2019) (K Units) Table North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by End User (2014-2019) Figure 2018 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by End User Figure Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate 2014-2019 (K Units) Figure Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate 2014-2019 (Million US$) Table Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Countries (2014-2019) (K Units) Table Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Countries (2014-2019) Figure 2018 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Countries Table Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Countries (2014-2019) (Million US$) Table Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Countries (2014-2019) Figure 2018 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Countries Figure Germany ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate (2014-2019) (K Units) Figure Germany ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2014-2019) (Million US$) Figure France ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate (2014-2019) (K Units) Figure France ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2014-2019) (Million US$) Figure UK ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate (2014-2019) (K Units) Figure UK ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2014-2019) (Million US$) Figure Italy ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate (2014-2019) (K Units) Figure Italy ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2014-2019) (Million US$) Figure Russia ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate (2014-2019) (K Units) Figure Russia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2014-2019) (Million US$) Table Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Product (2014-2019) (K Units) Table Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Product (2014-2019) Figure 2018 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Product Table Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by End User (2014-2019) (K Units) Table Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by End User (2014-2019) Figure 2018 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by End User Figure Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate 2014-2019 (K Units) Figure Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate 2014-2019 (Million US$) Table Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Countries (2014-2019) (K Units) Table Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Countries (2014-2019) Figure 2018 Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Countries Table Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Countries (2014-2019) (Million US$) Table Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Countries (2014-2019) Figure 2018 Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Countries Figure China ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate (2014-2019) (K Units) Figure China ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2014-2019) (Million US$) Figure Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate (2014-2019) (K Units) Figure Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2014-2019) (Million US$) Figure Korea ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate (2014-2019) (K Units) Figure Korea ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2014-2019) (Million US$) Figure India ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate (2014-2019) (K Units) Figure India ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2014-2019) (Million US$) Figure Australia ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate (2014-2019) (K Units) Figure Australia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2014-2019) (Million US$) Figure Indonesia ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate (2014-2019) (K Units) Figure Indonesia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2014-2019) (Million US$) Figure Malaysia ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate (2014-2019) (K Units) Figure Malaysia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2014-2019) (Million US$) Figure Philippines ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate (2014-2019) (K Units) Figure Philippines ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2014-2019) (Million US$) Figure Thailand ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate (2014-2019) (K Units) Figure Thailand ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2014-2019) (Million US$) Figure Vietnam ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate (2014-2019) (K Units) Figure Vietnam ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2014-2019) (Million US$) Figure Singapore ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate (2014-2019) (K Units) Figure Singapore ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2014-2019) (Million US$) Table Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Product (2014-2019) (K Units) Table Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Product (2014-2019) Figure 2018 Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Product Table Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by End User (2014-2019) (K Units) Table Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by End User (2014-2019) Figure 2018 Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by End User Figure Central & South America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate 2014-2019 (K Units) Figure Central & South America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate 2014-2019 (Million US$) Table Central & South America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Countries (2014-2019) (K Units) Table Central & South America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Countries (2014-2019) Figure 2018 Central & South America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Countries Table Central & South America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Countries (2014-2019) (Million US$) Table Central & South America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Countries (2014-2019) Figure 2018 Central & South America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Countries Figure Brazil ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate (2014-2019) (K Units) Figure Brazil ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2014-2019) (Million US$) Figure Argentina ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate (2014-2019) (K Units) Figure Argentina ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2014-2019) (Million US$) Table Central & South America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Product (2014-2019) (K Units) Table Central & South America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Product (2014-2019) Figure 2018 Central & South America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Product Table Central & South America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by End User (2014-2019) (K Units) Table Central & South America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by End User (2014-2019) Figure 2018 Central & South America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by End User Figure Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate 2014-2019 (K Units) Figure Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate 2014-2019 (Million US$) Table Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Countries (2014-2019) (K Units) Table Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Countries (2014-2019) Figure 2018 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Countries Table Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Countries (2014-2019) (Million US$) Table Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Countries (2014-2019) Figure 2018 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Countries Figure GCC Countries ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate (2014-2019) (K Units) Figure GCC Countries ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2014-2019) (Million US$) Figure Turkey ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate (2014-2019) (K Units) Figure Turkey ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2014-2019) (Million US$) Figure Egypt ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate (2014-2019) (K Units) Figure Egypt ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2014-2019) (Million US$) Figure South Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate (2014-2019) (K Units) Figure South Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate (2014-2019) (Million US$) Table Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Product (2014-2019) (K Units) Table Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Product (2014-2019) Figure 2018 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Product Table Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by End User (2014-2019) (K Units) Table Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by End User (2014-2019) Figure 2018 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by End User Table Stryker Company Details Table Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Stryker Recent Development Table Balt Company Details Table Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Balt Recent Development Table TERUMO Company Details Table TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table TERUMO Recent Development Table MicroPort Company Details Table MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table MicroPort Recent Development Table Acandis Company Details Table Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Acandis Recent Development Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Forecast by Regions 2019-2025 (K Units) Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share Forecast by Regions 2019-2025 Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Forecast by Regions 2019-2025 (Million US$) Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share Forecast by Regions 2019-2025 Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Forecast by Product 2019-2025 (K Units) Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share Forecast by Product 2019-2025 Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Forecast by Product 2019-2025 (Million US$) Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share Forecast by Product 2019-2025 Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Forecast by End User 2019-2025 (K Units) Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share Forecast by End User 2019-2025 Figure North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate Forecast (2019-2025) (K Units) Figure North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate Forecast (2019-2025) (K Units) Figure Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate Forecast (2019-2025) (K Units) Figure Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Central & South America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate Forecast (2019-2025) (K Units) Figure Central & South America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate Forecast (2019-2025) (K Units) Figure Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate Forecast (2019-2025) (Million US$) Table ICAD (Intracranial Atherosclerotic Disease) Pathology Value Chain Table ICAD (Intracranial Atherosclerotic Disease) Pathology Customers List Table ICAD (Intracranial Atherosclerotic Disease) Pathology Distributors List Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Stryker Balt TERUMO MicroPort Acandis